Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.96 USD | -2.49% | -4.39% | -37.38% |
Mar. 28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.38% | 2.74M | |
+19.41% | 40.09B | |
-.--% | 11.23B | |
+3.16% | 8.33B | |
+0.32% | 6.38B | |
-1.32% | 6.36B | |
-5.22% | 5.85B | |
+35.64% | 5.48B | |
-15.96% | 5.29B | |
-18.61% | 4.27B |
- Stock Market
- Equities
- RKDA Stock
- News Arcadia Biosciences, Inc.
- HC Wainwright Cuts Price Target on Arcadia Biosciences to $6 From $7, Maintains Buy Rating